Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2′-deoxycytidine against synovial sarcoma cell lines
Author(s) -
Kunihiko Numoto,
Aki Yoshida,
Shinsuke Sugihara,
Toshiyuki Kunisada,
Yuki Morimoto,
Yasushi Yoneda,
Yasuko Fujita,
Keiichiro Nishida,
Mamoru Ouchida,
Toshifumi Ozaki
Publication year - 2009
Publication title -
journal of cancer research and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 94
eISSN - 1432-1335
pISSN - 0171-5216
DOI - 10.1007/s00432-009-0632-2
Subject(s) - synovial sarcoma , deoxycytidine , sarcoma , cancer research , methylation , chemistry , microbiology and biotechnology , biology , medicine , pathology , chemotherapy , dna , biochemistry , gemcitabine
In this study, the methylation status of RASSF1A in synovial sarcomas and the effect of demethylation on synovial sarcoma were examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom